Stelios T Tzannis

Title: Innovator Stelios T. Tzannis: Pioneering Drug Delivery Systems

Introduction

Stelios T. Tzannis is a notable inventor based in Mountain View, California. He is recognized for his innovative contributions to the field of medical devices, particularly in the development of drug delivery systems. With a single patent to his name, Tzannis's work represents a significant advancement in how beneficial agents can be administered to patients.

Latest Patents

Stelios T. Tzannis holds a patent for a "Diffusional Implantable Delivery System." This patent describes a sustained release delivery system designed to deliver a beneficial agent effectively. The system features a reservoir containing the beneficial agent and a capillary channel that connects this reservoir with the outside environment. The design allows for controlled delivery rates based on the cross-sectional area and length of the capillary channel. Moreover, the system may incorporate a non-porous outer surface to ensure the impermeability of the delivery process, with the beneficial agent potentially formulated in a glassy sugar matrix for enhanced stability and release characteristics.

Career Highlights

Stelios T. Tzannis is associated with Alza Corporation, a company known for its innovation in drug delivery technologies. His work focuses on refining and expanding existing delivery methods to improve patient outcomes. Throughout his career, Tzannis has demonstrated a strong commitment to research and development in the medical field.

Collaborations

During his tenure at Alza Corporation, Tzannis has collaborated with esteemed colleagues, including Wouter E. Roorda and Keith E. Dionne. These collaborations have contributed to the advancement of drug delivery methods, enhancing the effectiveness and reliability of medical treatment options available to patients.

Conclusion

Stelios T. Tzannis stands as an influential figure in the realm of pharmaceutical innovation. His patent for the diffusional implantable delivery system exemplifies how targeted medical solutions can improve patient care. As he continues his work at Alza Corporation and collaborates with fellow experts, Tzannis contributes to the evolution of drug delivery systems, potentially transforming therapeutic practices in the future.